Startseite The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
Artikel Open Access

The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P

  • Xiaozhen Xu ORCID logo EMAIL logo , Na Xu , Shengtao Ma , Xinan Wu und Junling Zhang EMAIL logo
Veröffentlicht/Copyright: 30. Januar 2023

Abstract

C20H14BrO2P, monoclinic, P21/c (no. 14), a = 11.9837(14) Å, b = 9.9901(12) Å, c = 14.3621(18) Å, β = 94.873(2)°, V = 1713.2(4) Å3, Z = 4, R gt (F) = 0.0598, wR ref (F2) = 0.1925, T = 296.15 K.

CCDC no.: 2225985

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.03 × 0.03 × 0.02 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 2.50 mm−1
Diffractometer, scan mode: Bruker Smart APEX-II,
θmax, completeness: 27.6°, >99%
N(hkl)measured, N(hkl)unique, Rint: 10,063, 3867, 0.031
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 2649
N(param)refined: 217
Programs: CrysAlisPRO [1], SHELX [2, 3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
Br1 −0.06207 (5) 0.41460 (8) 0.32194 (5) 0.0722 (3)
C1 0.3372 (3) 0.3232 (4) 0.4407 (3) 0.0303 (9)
C2 0.4041 (4) 0.3439 (5) 0.5254 (3) 0.0397 (10)
H2 0.4559 0.2791 0.5465 0.048*
C3 0.3935 (5) 0.4575 (5) 0.5766 (3) 0.0471 (12)
H3 0.4389 0.4705 0.6316 0.056*
C4 0.3151 (5) 0.5537 (6) 0.5466 (4) 0.0495 (13)
H4 0.3079 0.6308 0.5819 0.059*
C5 0.2478 (4) 0.5357 (5) 0.4650 (3) 0.0446 (11)
H5 0.1950 0.6001 0.4451 0.054*
C6 0.2595 (4) 0.4209 (4) 0.4128 (3) 0.0319 (9)
C7 0.1832 (3) 0.3069 (4) 0.2735 (3) 0.0291 (9)
C8 0.2488 (3) 0.1984 (4) 0.2836 (3) 0.0321 (9)
H8 0.2398 0.1326 0.2377 0.039*
C9 0.0969 (3) 0.3247 (4) 0.1942 (3) 0.0299 (9)
C10 −0.0110 (4) 0.3744 (5) 0.2034 (3) 0.0395 (10)
C11 −0.0880 (4) 0.3874 (5) 0.1257 (4) 0.0472 (13)
H11 −0.1593 0.4206 0.1328 0.057*
C12 −0.0594 (5) 0.3516 (6) 0.0394 (4) 0.0535 (14)
H12 −0.1115 0.3599 −0.0121 0.064*
C13 0.0466 (5) 0.3031 (6) 0.0278 (4) 0.0542 (14)
H13 0.0660 0.2790 −0.0313 0.065*
C14 0.1235 (4) 0.2906 (5) 0.1048 (3) 0.0445 (11)
H14 0.1948 0.2586 0.0966 0.053*
C15 0.4860 (4) 0.1769 (4) 0.3307 (3) 0.0308 (9)
C16 0.5701 (4) 0.0904 (5) 0.3673 (3) 0.0394 (11)
H16 0.5562 0.0310 0.4149 0.047*
C17 0.6744 (4) 0.0936 (5) 0.3323 (4) 0.0508 (14)
H17 0.7309 0.0372 0.3574 0.061*
C18 0.6951 (4) 0.1790 (6) 0.2612 (4) 0.0521 (14)
H18 0.7648 0.1784 0.2371 0.063*
C19 0.6125 (4) 0.2664 (6) 0.2249 (4) 0.0485 (12)
H19 0.6269 0.3254 0.1773 0.058*
C20 0.5087 (4) 0.2650 (5) 0.2600 (3) 0.0363 (10)
H20 0.4534 0.3239 0.2360 0.044*
O1 0.1891 (3) 0.4150 (3) 0.3313 (2) 0.0393 (8)
O2 0.3365 (3) 0.0466 (3) 0.4319 (2) 0.0432 (8)
P1 0.35086 (9) 0.17093 (11) 0.37737 (8) 0.0288 (3)

Source of materials

A modified synthesis that was similar to previous Xiao’s report was performed [5, 6]. (2-Bromophenyl)diphenylphosphine (1 mmol) and 2-bromophenacyl bromide (1.1 mmol) were dissolved in toluene (10 mL) in a Schlenk bottle. After stirring at 90 °C for 3 h, the reaction mixture was cooled to room temperature and then t-BuOK (4.5 mmol) and Pd(PPh3)3 (0.1 mmol) were added under an argon atmosphere. The reaction mixture was stirred at 110 °C for 5 h, and then cooled to room temperature. An aqueous NaOH solution (1 M) was added directly. Stirring was continued at room temperature for 1 h and then the organic layer was separated. The aqueous layer was further extracted with CH2Cl2 (10 mL × 2). All combined organic solutions were dried with anhydrous Na2SO4, and the solvent was removed under reduced pressure. The residue was column chromatographied (petroleum ether/ethyl acetate) to afford the title compound (349 mg, 88%).

Experimental details

All H atoms were included in calculated positions and refined as riding atoms with 1.2 1.2Ueq(C) for all H atoms.

Comment

Heterocycles containing phosphorus are very attractive due to their expected bioactivity [7], [8], [9]. Phosphachromone, an analog of chromone, showed significant inhibition activities in a human breast cancer cell line MDA-MB-468 [10], [11], [12]. 1,4-Diphenylphosphachromone containing a phosphachromone skeleton could be used for the development of novel pharmaceuticals. In the title compound (see the figure), the bond length and bond angle of the compound are within the normal range [5, 6, 1012]. The molecule consists of phachromone skeleton, a 2-(2-bromophenyl) substituent and a 4-phenyl substituent. The detailed molecular structure showed that the bicyclic subunit is planar, the phosphorus center (P1) adopted a tetrahedral geometry, and the dihedral angle (C8–C7–C9–C10) between the 2-bromobenzene and the phosphachromone skeleton is 42.9°, which is different to methoxy derivative that reported in Ref. [5] due to the steric hindrance of the ortho-bromine. The bond length of exocyclic P1–C15 at 1.806(4) Å is longer than those of two endocyclic P–C bonds (1.787(4) Å and 1.762(4) Å), which are similar to methoxy and thiophene derivatives [5].


Corresponding authors: Xiaohen Xu, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, People’s Republic of China, E-mail: ; and Junling Zhang, Technology Center, China Tobacco Henan Industrial Co., Ltd., Zhengzhou 450016, People’s Republic of China, E-mail:

Xiaozhen Xu and Junling Zhang directed the project and co-wrote the manuscript.


Acknowledgements

This work was supported by Zhangzhou Affiliated Hospital of Fujian Medical University, Hefei BOE (Beijing Oriental Electronics) Hospital and Technology Center, China Tobacco Henan Industrial Co., Ltd. Also, we appreciate Haiyang Huang in Jiangxi Science and Technology Normal University for some data analysis.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Oxford Diffraction Ltd. CrysAlis rED (Version 1.171. 31.2) and ABSPACK in CrysAlis rED. In CrysAlisPRO; Abingdon, Oxfordshire: England, 2006.Suche in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.10.1107/S2053273314026370Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

5. Xu, S., Huang, H., Yan, Z., Xiao, Q. Pd (0)-catalyzed intramolecular “Ylide–Ullmann-Type” cyclization of carbonyl-stabilized phosphonium ylides and access to phosphachromones by exocyclic P–C cleavage. Org. Lett. 2019, 21, 10018–10022; https://doi.org/10.1021/acs.orglett.9b03948.Suche in Google Scholar PubMed

6. Xu, S., Huang, H., Yuan, C., Liu, F., Ding, H., Xiao, Q. Synthesis and photophysical properties of donor-substituted phenyl-phosphachromones as potential TADF materials. Org. Chem. Front. 2021, 8, 1747–1755; https://doi.org/10.1039/d1qo00121c.Suche in Google Scholar

7. Peng, A. Y., Ding, Y. X. The synthesis of phosphaisocoumarins by Cu(I)-catalyzed intramolecular cyclization of o-ethynylphenylphosphonic acid monoesters. J. Am. Chem. Soc. 2003, 125, 15006–15007; https://doi.org/10.1021/ja038627f.Suche in Google Scholar PubMed

8. Li, B., Zhou, B., Lu, H., Ma, L., Peng, A. Y. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase. Eur. J. Med. Chem. 2010, 45, 1955–1963; https://doi.org/10.1016/j.ejmech.2010.01.038.Suche in Google Scholar PubMed

9. Tang, W., Ding, Y. X. Synthesis of phosphaisoquinolin-1-ones by Pd(II)-catalyzed cyclization of o-(1-alkynyl) phenylphosphonamide monoesters. J. Org. Chem. 2006, 71, 8489–8492; https://doi.org/10.1021/jo0614644.Suche in Google Scholar PubMed

10. Xie, L., Ma, J., Ding, Y. X. Ag(I)-catalyzed cyclization reaction of ethyl o-hydroxyphenylethynylphosphinates to phosphachromones. Tetrahedron Lett. 2008, 49, 847–850; https://doi.org/10.1016/j.tetlet.2007.11.166.Suche in Google Scholar

11. Xie, L., Ma, J., Ding, Y. X. Synthesis of 3-allyl-4-phosphachromones by cyclized coupling of ethyl o-hydroxyphenyl (ethynyl) phosphinate with allyl bromide. Chin. J. Chem. 2008, 26, 1295–1298; https://doi.org/10.1002/cjoc.200890235.Suche in Google Scholar

12. Peng, A. Y., Xie, L., Ding, Y., Wang, Y., Ding, Y. X. Synthetic strategy of o-hydroxyphenyl (ethynyl) phosphinates. Chin. J. Chem. 2009, 27, 1387–1390; https://doi.org/10.1002/cjoc.200990232.Suche in Google Scholar

Received: 2023-01-03
Accepted: 2023-01-15
Published Online: 2023-01-30
Published in Print: 2023-04-25

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
  4. The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
  5. Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
  6. Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
  7. Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
  8. The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
  9. The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
  10. Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
  11. The crystal structure of strictic acid, C20H26O3
  12. Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
  13. The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
  14. The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
  15. Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
  16. Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
  17. Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
  18. Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
  19. Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
  20. Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
  22. Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
  23. Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
  24. Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
  25. Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  26. Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
  27. Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
  28. Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
  29. Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
  30. Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
  31. Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
  32. The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
  33. The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
  34. Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
  35. Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
  36. Crystal structure of niobium trigallide, NbGa3
  37. Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
  38. Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
  39. The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
  40. The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
  41. Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
  42. Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
  43. The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
  44. Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
  45. Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
  46. Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
  47. Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
  48. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
  49. The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
  50. Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
  51. Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
  52. Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
  53. Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
  54. Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
  55. The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
  56. Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
  57. The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
  58. Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
  59. Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
  60. Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
  61. Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
  62. Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
  63. Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
  64. Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
  65. Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
  66. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
  67. The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
  68. The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
  69. Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
  70. Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
  71. One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
  72. The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
  73. Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
  74. The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
  75. The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
  76. The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
  77. Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
  78. Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9
Heruntergeladen am 10.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0005/html
Button zum nach oben scrollen